Wednesday, August 17, 2016

Inspyr Therapeutics Announces the Initiation of a Phase 2 Clinical Trial of Mipsagargin for Newly Diagnosed Prostate Cancer Patients

with treatment-naïve prostate cancer prior to surgical removal of the
tumor. Patients in … supply of prostate
tumors and killing prostate cancer cells, which could lead to tumor
regression … with
glioblastoma (brain cancer), prostate cancer, and clear cell renal
cancer. For additional information …

No comments:

Post a Comment